Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma

Figure 5

Comparison of CD3⁺ T cell infiltration between EGFR-mutant and wild-type lung adenocarcinoma tumor microenvironment.